Results

1–10 of 172 results for NFL

Prophylactic Intraocular Pressure–Lowering Measures in Antivascular Endothelial Growth Factor Therapy: Systematic Review and Meta-Analysis
Parnian Arjmand, MD, MSc, FRCSC, DABO
Annual Meeting Talks
2022
Results from Part 1 of the Phase 2/3 SIGLEC Trial Assessing AVD-104 for Geographic Atrophy: Glyco-immunologic Modulation of Macrophage Activity
Rishi P. Singh, MD
Updates from the Field
2024
Endophthalmitis After Intravitreal Injections with 0.05% Aqueous Chlorhexidine vs 5% Povidone-Iodine as Ocular Antiseptics
Murtaza K Adam, MD
Annual Meeting Talks
2022
Biomarkers in the Vitreous Humor Correlate With Alzheimer’s Disease and Chronic Traumatic Encephalopathy in Postmortem Eyes and Brain
Manju L. Subramanian, MD
Annual Meeting Talks
2022
Association of OCT Choroidal Thickness Maps and Automated Fixed-Depth Intensity Maps With Disease Activity in Birdshot Chorioretinopathy
Keirnan Willett, MD
Annual Meeting Talks
2022
Ocular Involvement in Candidemia Diagnosed by T2 vs Blood Culture With Recommendations on Screening for Endogenous Candida Endophthalmitis
John O. Mason, MD
Annual Meeting Talks
2022
Efficacy of Suprachoroidal Triamcinolone Acetonide Injectable Suspension in the Treatment of Macular Edema in Patients With Chronic Uveitis
Christopher R Henry, MD
Annual Meeting Talks
2022
Ultra-Widefield Fluorescein Angiography and OCT Findings in Children and Young Adults With Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy
Arjun B Sood, MD
Annual Meeting Talks
2022
Early Vitrectomy for Post-Injection Endophthalmitis: an IRIS® Registry Analysis
Magdalena G Krzystolik, MD
Updates from the Field
2024
New Treatment Paradigm for Infectious Endophthalmitis: Results from the Mexican Endophthalmitis Study Group Protocol 1 and 3
Raul Velez-Montoya, MD
Updates from the Field
2024